IMM News: Immutep to Participate in The JMP Securities Hematology and Oncology Summit - 3rd Dec 2022, 12:00am

You must log in or register to reply here.

Similar threads

annb0t
IMM News: With 49% stake, Immutep Limited (ASX:IMM) seems to have captured institutional investors' interest - 7th Jul 2023, 7:57am
Replies
0
Views
98
annb0t
annb0t
annb0t
IMM News: Immutep Completes A$80 Million Capital Raise - 27th Jun 2023, 10:00pm
Replies
0
Views
141
annb0t
annb0t
annb0t
IMM News: Immutep Secures Third United States Patent for Eftilagimod Alpha in Combination with a PD-1 Pathway - 27th Jun 2023, 10:00pm
Replies
0
Views
129
annb0t
annb0t
annb0t
IMM News: Immutep Granted United States Patent for IMP761, a First-in-Class Agonist Antibody Targeting LAG-3 - 20th Jun 2023, 10:00pm
Replies
0
Views
96
annb0t
annb0t
annb0t
IMM News: The 12% return this week takes Immutep's (ASX:IMM) shareholders three-year gains to 96% - 10th Jun 2023, 7:21am
Replies
0
Views
145
annb0t
annb0t
Top Bottom